Daniel Hochbaum

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Harvard College, University of Alberta, Massachusetts Institute of Technology. Active years: 2015-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Hochbaum. Retrieved from https://idiyas.com/inventor/daniel-hochbaum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 40(Granted Patents)

Company Filing History:

University of Alberta

patents

1 out of 8,586

Massachusetts Institute of Technology

patents

where one patent can have more than one assignee

Years Active: 2015-2020

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10800829 - Optogenetic probes for measuring membrane potential (2020-10-13),

2. 10457715 - Optogenetic probes for measuring membrane potential (2019-10-29),

3. 10392426 - Blue-light-activated ion channel polypeptides and uses thereof (2019-08-27),

4. 10161937 - Systems, methods, and workflows for optogenetics analysis (2018-12-25),

5. 9702874 - Systems, methods, and workflows for optogenetics analysis (2017-07-11),

6. 9518103 - Optogenetic probes for measuring membrane potential (2016-12-13),

7. 9207237 - Systems, methods, and workflows for optogenetics analysis (2015-12-08),

Title: The Innovative Journey of Daniel Hochbaum: A Pioneer in Optogenetics

Introduction

Daniel Hochbaum is an esteemed inventor based in Cambridge, MA, recognized for his significant contributions to the field of optogenetics. With a remarkable portfolio consisting of seven patents, Hochbaum's work focuses on advancing optical techniques for measuring cellular membrane potential.

Latest Patents

Two of Hochbaum's latest patents encompass the development of variants of archaerhodopsin for optical measurement of membrane potential. These patents detail the innovative polynucleotides encoding the variants, along with nucleic acid constructs, vectors, and cells that incorporate these polynucleotides and polypeptides. The methods outlined for utilizing these variants offer groundbreaking potential in neuroscience and cellular biology.

Career Highlights

Throughout his career, Daniel Hochbaum has worked with prestigious institutions such as Harvard College and the University of Alberta. His expertise in optogenetics has established him as a key figure in the intersection of biology and technology, especially in exploring how light can control biological processes.

Collaborations

Hochbaum has collaborated with prominent scientists including Adam Ezra Cohen and Joel Kralj. These partnerships have fostered a rich environment of interdisciplinary research, allowing for the exchange of ideas and the advancement of techniques within the field.

Conclusion

In conclusion, Daniel Hochbaum's inventive spirit and dedication to scientific exploration have yielded impactful innovations in optogenetics. His patents not only reflect his creativity but also showcase the potential for future developments in measuring and influencing neural activities, thereby paving the way for breakthroughs in medical and biological research.

Profile summary based on public USPTO records.